CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
3.610
-0.170 (-4.50%)
At close: May 15, 2026, 4:00 PM EDT
3.619
+0.009 (0.24%)
After-hours: May 15, 2026, 7:49 PM EDT
CytomX Therapeutics Employees
CytomX Therapeutics had 69 employees as of December 31, 2025. The number of employees decreased by 52 or -42.98% compared to the previous year.
Employees
69
Change (1Y)
-52
Growth (1Y)
-42.98%
Revenue / Employee
$515,101
Profits / Employee
-$900,623
Market Cap
785.91M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 69 | -52 | -42.98% | 69 | 0 |
| Dec 31, 2024 | 121 | -1 | -0.82% | 119 | 2 |
| Dec 31, 2023 | 122 | 4 | 3.39% | 120 | 2 |
| Dec 31, 2022 | 118 | -60 | -33.71% | 116 | 2 |
| Dec 31, 2021 | 178 | 32 | 21.92% | 174 | 4 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Kura Oncology | 260 |
| Xencor | 260 |
| Geron | 258 |
| Absci | 140 |
| Aura Biosciences | 113 |
| Vor Biopharma | 76 |
| Alto Neuroscience | 68 |
| Bright Minds Biosciences | 26 |
CTMX News
- 4 days ago - CytomX Therapeutics price target lowered to $11 from $17 at H.C. Wainwright - TheFly
- 8 days ago - CytomX Therapeutics reports Q1 EPS (10c), consensus (11c) - TheFly
- 8 days ago - CytomX Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 8 days ago - CytomX Therapeutics Announces Q1 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 15 days ago - CytomX Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026 - GlobeNewsWire
- 4 weeks ago - CytomX Therapeutics participates in a conference call with JPMorgan - TheFly
- 7 weeks ago - CytomX Therapeutics price target raised to $12 from $10 at Piper Sandler - TheFly
- 2 months ago - CytomX Therapeutics price target raised to $16 from $10 at Barclays - TheFly